Delivery Order SPE2DB20D1102-SPE2DB24FC6PQ
Award Date
6/28/24
Potential Completion Date
7/22/24
Potential Value
$7.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract has a ceiling value of $18,783.50 and is a Delivery Order under a larger Indefinite Delivery...
This federal contract award is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $3,756.72, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office...
This federal contract award is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML medical products. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $35,816.00 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...
This federal contract award is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical facilities. The $11,270.10 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a for-profit organization and a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The award is part of an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, valued at up...
This federal contract award is a delivery order with a firm fixed price of $1,732.55 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is with the Defense Logistics Agency (DLA), a Defense agency, to provide HYPERRAB 300 UNIT/ML VIALML. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $7,163.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a medical product, with a completion date of May 1, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $1,039.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total ceiling value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed-price delivery order contract worth $8,932.56 to supply HYPERRAB 300 UNIT/ML VIALML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide pharmaceuticals and medical supplies to DLA Troop Support Medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Firm Fixed Price Delivery Order to provide HYPERRAB 300 UNIT/ML VIAL 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $13,494.72 with a completion date of July 15, 2024, is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves...
This federal contract award, with a total ceiling value of $7,513.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML, a critical pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply...